Clinical Trial

Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product

Name: Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product — clinical trial record (NCT06925685)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation

View on ClinicalTrials.gov →

Summary

An observational, long-term follow up (LTFU) study of participants who received an allogeneic CAR T product in a prior clinical study. Participants will be followed for 15 years after their last infusion of an allogenic CAR T cell product.

Trial Details

NCT Number	NCT06925685
Lead Sponsor	Allogene Therapeutics
Conditions	Hematologic Malignancies, Solid Tumors
Enrollment	50 participants
Start Date	2025-01-31
Primary Completion	2039-01 (estimated)
Study Completion	2039-01 (estimated)
Updated on ClinicalTrials.gov	2025-04-13